BioPharmX Corporation (TMBR)

Last Price:  

Company Description

Timber Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on the development and commercialization of treatments for orphan dermatologic diseases. The Company is initially engaged on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis, tuberous sclerosis complex and localized scleroderma. Timber Pharmaceuticals Inc., formerly known as BioPharmX Corporation, is based in NJ, United States.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $0.06M
Net Income (Most Recent Fiscal Year) $-9.69M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) --
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) -248720.00%
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) -4444.44%
Return on Assets (Trailing 12 Months) -266.62%
Current Ratio (Most Recent Fiscal Quarter) 0.17
Quick Ratio (Most Recent Fiscal Quarter) 0.17
Debt to Common Equity (Most Recent Fiscal Quarter) 1.15
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $-0.22
Earnings per Share (Most Recent Fiscal Quarter) --
Earnings per Share (Most Recent Fiscal Year) --
Diluted Earnings per Share (Trailing 12 Months) --
Stock
Exchange NYSEMKT
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 11.85M
Free Float 11.45M
Market Capitalization $26.42M
Average Volume (Last 20 Days) 0.95M
Beta (Past 60 Months) 0.22
Percentage Held By Insiders (Latest Annual Proxy Report) 3.40%
Percentage Held By Institutions (Latest 13F Reports) 23.56%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%